Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys
The material contained in this article was presented, in part, in poster form at the Annual Meeting of the Association for Research in Vision and Ophthalmology, April 30–May 4, 2006, Fort Lauderdale, Florida.
References (18)
Anti inflammatory therapy ford ry eye
Am J Ophthalmol.
(2004)- et al.
Relation between signs and symptoms of dry eye in the elderly. A populationbased perspective
Ophthalmology
(1997) - et al.
Prevalence of dry eye syndrome among US women
Am J Ophthalmol.
(2003) - et al.
The incidence and risk factors for developing dry eye after myopic LASIK
Am J Ophthalmol.
(2006) - et al.
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease
Ophthalmology
(2000) - et al.
Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to severe dry eye disease: A dose-ranging, randomized trial
Ophthalmology
(2000) Inflammation: A unifying theory for the origin of dry eye syndrome
Manag Care.
(2003)- et al.
The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity
Invest Ophthalmol Vis Sci.
(2003) - et al.
Dry eye diagnosis and management in 2004
Curr Opin Ophthalmol
(2004)
There are more references available in the full text version of this article.
Cited by (13)
Advancements in anti-inflammatory therapy for dry eye syndrome
2009, OptometryCitation Excerpt :Although the beneficial effects of this drug for dry eye patients do not occur instantaneously, subjective symptomatic improvement seems to occur earlier than the resolution of objective clinical signs.61 Trattler et al.68 surveyed 0.05% CsA-treated patients regarding compliance and onset of symptom relief. Seventy percent of noncompliant patients and 73% of compliant patients noted relief of dry eye symptoms within a 5-week period.
Impact of dry eye disease treatment on patient quality of life
2024, Frontiers in MedicineAssessment of the compliance with 0.1% cyclosporine a in dry-eye patients with sjögren's syndrome
2021, Journal of Korean Ophthalmological SocietyOphthalmology Provider Ratings and Patient, Disease, and Appointment Factors
2021, Journal of Patient ExperienceA hospital based study of prevalence of dry eye in tertiary care hospital of Nepal
2021, Kathmandu University Medical JournalTreatment satisfaction among patients using anti-inflammatory topical medications for dry eye disease
2020, Clinical Ophthalmology
Copyright © 2006 Published by Elsevier Inc.